This inventor holds 1 USPTO granted patent. Top assignee: Talecris Biotherapeutics, Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Jarrett C. Terry: Innovator in Thrombolytic Therapy
Introduction
Jarrett C. Terry is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotherapeutics, particularly in the area of thrombolytic therapy. His innovative work has led to the development of a unique process that enhances the stability and efficacy of plasmin compositions.
Latest Patents
Jarrett C. Terry holds a patent for a process titled "Process for the production of a reversibly inactive acidified plasmin composition." This patent discloses a method for producing a reversibly inactive acidified plasmin by activating plasminogen. The process also includes the production of purified plasminogen, which is typically purified from a fraction obtained during the separation of immunoglobulin from a Fraction II+III chromatographic process. The produced plasmin is isolated and stored with a low pH-buffering capacity agent, ensuring a substantially stable formulation. This reversibly inactive acidified plasmin has potential applications in thrombolytic therapy.
Career Highlights
Jarrett C. Terry is currently associated with Talecris Biotherapeutics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in improving therapeutic options for patients requiring thrombolytic treatments.
Collaborations
Some of his notable coworkers include Rita T. Bradley and Scott A. Cook. Their collaborative efforts contribute to the innovative environment at Talecris Biotherapeutics, Inc.
Conclusion
Jarrett C. Terry's contributions to the field of biotherapeutics, particularly through his patented process for plasmin composition, highlight his role as an innovator in thrombolytic therapy. His work continues to impact the medical community positively.